| Primary |
| Premature Labour |
62.9% |
| Drug Use For Unknown Indication |
17.1% |
| Asthma |
11.4% |
| Condition Aggravated |
2.9% |
| Influenza A Virus Infection |
2.9% |
| Prophylaxis |
2.9% |
|
| Drug Exposure During Pregnancy |
21.4% |
| Maternal Drugs Affecting Foetus |
7.1% |
| Off Label Use |
7.1% |
| Restlessness |
7.1% |
| Cerebral Haemorrhage Foetal |
3.6% |
| Circumstance Or Information Capable Of Leading To Medication Error |
3.6% |
| Cystocele |
3.6% |
| Developmental Delay |
3.6% |
| Exposure During Pregnancy |
3.6% |
| Heart Rate Increased |
3.6% |
| Hypotension |
3.6% |
| Neonatal Disorder |
3.6% |
| Palpitations |
3.6% |
| Pre-eclampsia |
3.6% |
| Rash |
3.6% |
| Rash Maculo-papular |
3.6% |
| Respiratory Arrest |
3.6% |
| Respiratory Rate Increased |
3.6% |
| Salivary Duct Obstruction |
3.6% |
| Sleep Disorder |
3.6% |
|
| Secondary |
| Asthma |
23.5% |
| Status Asthmaticus |
16.4% |
| Product Used For Unknown Indication |
9.9% |
| Bronchitis |
6.8% |
| Drug Use For Unknown Indication |
5.2% |
| Chronic Obstructive Pulmonary Disease |
4.4% |
| Pyrexia |
4.2% |
| Hypertension |
3.4% |
| Drug Exposure During Pregnancy |
3.1% |
| Foetal Cardiac Disorder |
2.9% |
| Sedation |
2.9% |
| Bronchopneumonia |
2.3% |
| Bronchitis Chronic |
2.1% |
| Coronary Artery Disease |
2.1% |
| Foetal Heart Rate Decreased |
2.1% |
| Prophylaxis |
2.1% |
| Premature Labour |
1.8% |
| Atrial Fibrillation |
1.6% |
| Osteoporosis |
1.6% |
| Pneumonia Haemophilus |
1.6% |
|
| Drug Ineffective |
11.5% |
| Neutropenia |
9.8% |
| Foetal Growth Restriction |
6.6% |
| Metabolic Alkalosis |
6.6% |
| Oligohydramnios |
6.6% |
| Insomnia |
4.9% |
| Medication Error |
4.9% |
| Rash Maculo-papular |
4.9% |
| Renal Tubular Necrosis |
4.9% |
| Septic Shock |
4.9% |
| Stevens-johnson Syndrome |
4.9% |
| Asthma |
3.3% |
| Deafness |
3.3% |
| Exophthalmos Congenital |
3.3% |
| General Physical Health Deterioration |
3.3% |
| Heparin-induced Thrombocytopenia |
3.3% |
| Metabolic Acidosis |
3.3% |
| Placental Transfusion Syndrome |
3.3% |
| Renal Failure Acute |
3.3% |
| Tachycardia Foetal |
3.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
30.2% |
| Product Used For Unknown Indication |
15.7% |
| Asthma |
13.8% |
| Chronic Obstructive Pulmonary Disease |
4.1% |
| Rheumatoid Arthritis |
3.9% |
| Behcet's Syndrome |
3.8% |
| Depression |
3.7% |
| Hypertension |
2.6% |
| Sedation |
2.6% |
| Cardiac Disorder |
2.3% |
| Emphysema |
2.2% |
| Anxiety |
2.0% |
| Medical Diet |
2.0% |
| Peritonitis |
2.0% |
| Osteoporosis |
1.7% |
| Analgesic Therapy |
1.5% |
| Ill-defined Disorder |
1.5% |
| Anaemia |
1.5% |
| Bronchial Disorder |
1.4% |
| Pneumonia |
1.4% |
|
| Vomiting |
18.6% |
| Ventricular Septal Defect |
11.8% |
| Renal Failure |
7.4% |
| Drug Exposure During Pregnancy |
5.9% |
| Wheezing |
5.4% |
| Williams Syndrome |
5.4% |
| Asthma |
4.4% |
| Umbilical Cord Prolapse |
4.4% |
| Deep Vein Thrombosis |
3.9% |
| Cytolytic Hepatitis |
3.4% |
| Drug Interaction |
3.4% |
| Premature Baby |
3.4% |
| Stillbirth |
3.4% |
| Cardiac Failure |
2.9% |
| Drug Ineffective |
2.9% |
| Pyrexia |
2.9% |
| Swelling Face |
2.9% |
| Colitis |
2.5% |
| Myocardial Infarction |
2.5% |
| Pharyngeal Oedema |
2.5% |
|
